Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.08. | BIMobject AB: BIMobject: Interim Report April-June 2024 | 40 | GlobeNewswire (Europe) | Second quarter financial highlightsARR in constant currencies of MSEK 138.4 (128.1) at end of quarter, +8%Net sales of MSEK 41.8 (39.6), +6%, including a currency effect of +1%Net sales from recurring... ► Artikel lesen | |
02.08. | Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination | 118 | GlobeNewswire (Europe) | SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport"), an AI technology company serving enterprises' customer... ► Artikel lesen | |
02.08. | OCI N.V.: OCI Global Reports Q2 2024 Results | 273 | GlobeNewswire (Europe) | Financial Highlights
• OCI Global (Euronext: OCI) reported total Q2 2024 revenues of $1,211 million, a 12% reduction YoY, and total Q2 2024 adjusted EBITDA of $296 million, a decrease of 9% YoY.... ► Artikel lesen | |
02.08. | Zevra Therapeutics: FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C | 316 | GlobeNewswire (Europe) | CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that the U.S. Food and... ► Artikel lesen | |
02.08. | Digicann Ventures Inc.: Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction | 413 | GlobeNewswire (Europe) | /Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or the... ► Artikel lesen | |
02.08. | Bluewater Acquisition Corp. and AlphaDelta Management Corp. Announce Termination of LOI | 164 | GlobeNewswire (Europe) | CALGARY, Alberta, and VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bluewater Acquisition Corp. ("Bluewater") (TSXV: BAQ.P) and AlphaDelta Management Corp. ("ADM") jointly announce... ► Artikel lesen | |
02.08. | JOYY Inc.: JOYY Announces Leadership Transition | 150 | GlobeNewswire (Europe) | SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (Nasdaq: YY) ("JOYY" or the "Company"), a global technology company, today announced that its board of directors (the "Board") has approved a... ► Artikel lesen | |
02.08. | Chibougamau Independent Mines Inc.: Termination of TomaGold's Option for the Acquisition of Chibougamau's East Block | 209 | GlobeNewswire (Europe) | ROUYN-NORANDA, Québec, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC... ► Artikel lesen | |
02.08. | Tourmaline Bio, Inc.: Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 | 164 | GlobeNewswire (Europe) | Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous administration... ► Artikel lesen | |
02.08. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 129 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
02.08. | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 163 | GlobeNewswire (Europe) | SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development... ► Artikel lesen | |
02.08. | Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 145 | GlobeNewswire (Europe) | WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies... ► Artikel lesen | |
02.08. | TWC Enterprises Limited Announces Second Quarter 2024 Results and Eligible Dividend | 126 | GlobeNewswire (Europe) | KING CITY, Ontario, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Consolidated Financial Highlights (unaudited) (in thousands of dollars except per share amounts)Three months endedSix months endedJune... ► Artikel lesen | |
02.08. | NEXGOLD MINING CORP: NexGold Mining Announces New OTCQX Ticker Symbol | 265 | GlobeNewswire (Europe) | TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG) (OTCQX: NXGCF) (the "Company" or "NexGold") is pleased to announce that it will begin trading at market open on August... ► Artikel lesen | |
02.08. | Helport AI Limited and Tristar Acquisition I Corp. Announce Closing of Business Combination and listing on Nasdaq | 215 | GlobeNewswire (Europe) |
SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport") (Nasdaq: HPAI), an AI technology company serving enterprise... ► Artikel lesen | |
02.08. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 207 | GlobeNewswire (Europe) | BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024... ► Artikel lesen | |
02.08. | JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency | 279 | GlobeNewswire (Europe) | Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the "Company"), a company that specializes in providing one-stop comprehensive education supporting services to adult... ► Artikel lesen | |
02.08. | electroCore, Inc.: electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) | 186 | GlobeNewswire (Europe) | ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August... ► Artikel lesen | |
02.08. | Infinera Corporation Reports Second Quarter 2024 Financial Results | 527 | GlobeNewswire (Europe) | SAN JOSE, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released financial results for its second quarter ended June 29, 2024. GAAP revenue for the quarter was... ► Artikel lesen | |
02.08. | Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 154 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 31, 2024, the Compensation... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.932 |
EVOTEC | 2.185 |
TUI | 1.874 |
BAYER | 1.804 |
NVIDIA | 1.692 |
NEL | 1.296 |
RENK GROUP | 1.157 |
RHEINMETALL | 1.050 |
TESLA | 885 |
PALANTIR TECHNOLOGIES | 837 |
DEUTSCHE BANK | 785 |
VOLKSWAGEN | 766 |
MICROSTRATEGY | 724 |
BYD | 708 |
PLUG POWER | 672 |
COMMERZBANK | 664 |
BASF | 643 |
JINKOSOLAR | 621 |
MERCEDES-BENZ | 601 |
AMAZON | 583 |
DEUTSCHE TELEKOM | 564 |
INTEL | 559 |
BMW | 554 |
ALLIANZ | 545 |
THYSSENKRUPP | 544 |